FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Mixing Medications and Dietary Supplements Can Endanger Your Health FDA FDA Issues Flurry of Warning Letters to Companies Making Unapproved Claims about CBD and Delta 8 Products Buchanan Ingersoll & Rooney PC On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law